Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;34(1):e14502.
doi: 10.1111/dth.14502. Epub 2020 Nov 10.

Chilblains-like lesions and SARS-CoV-2 in children: An overview in therapeutic approach

Piero Pavone  1 , Silvia Marino  2 , Lidia Marino  3 , Giovanni Cacciaguerra  3 , Claudio Guarneri  4 , Giuseppe Nunnari  4 , Rosaria Taibi  5 , Livia Marletta  4 , Raffaele Falsaperla  2   6
Affiliations
Review

Chilblains-like lesions and SARS-CoV-2 in children: An overview in therapeutic approach

Piero Pavone et al. Dermatol Ther. 2021 Jan.

Abstract

SARS-CoV-2 (Severe Acute Respiratory Syndrome, Coronavirus, type 2) is the virus responsible for the global pandemic of Coronavirus disease 2019 (COVID-19) that began in China in December 2019. The variability of nasal olfactory symptoms in pediatric patients is interlinked with possible warning signs, including respiratory, gastrointestinal, ocular, or dermatological symptoms. Skin findings in patients with COVID-19 can range from petechiae to papulovesicular rashes to diffuse urticaria and can be confused with rashes of non-COVID-19 conditions. These lesions typically appear early during COVID-19 and are thought to be secondary to viral replication or circulating cytokines. Herein, we discuss two pediatric cases, presenting with skin lesions, which tested positive for SARS-CoV-2, thus, briefly reviewing current literature for similar reports and related management. Although these lesions heal spontaneously in most cases, an adequate "targeted" therapeutic approach can shorten the time and the discomfort of the skin disease.

Keywords: coronavirus disease 2019; pediatricssevere acute respiratory syndrome-Coronavirus type-2; therapy.

PubMed Disclaimer

References

REFERENCES

    1. Pavone P, Ceccarelli M, Taibi R, La Rocca G, Nunnari G. Outbreak of COVID-19 infection in children: fear and serenity. Eur Rev Med Pharmacol Sci. 2020;24:4572-4575.
    1. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355-368. https://doi.org/10.1097/INF.0000000000002660.
    1. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):e20200702. http://dx.doi.org/10.1542/peds.2020-0702.
    1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13):1199-1207. https://doi.org/10.1056/NEJMoa2001316.
    1. Heymann DL, Shindo N. WHO scientific and technical advisory group for infectious hazards. COVID-19: what is next for public health? Lancet. 2020;395:542-545.

LinkOut - more resources